Coherus Oncology, Inc. - Common Stock (CHRS)

CUSIP: 19249H103

Q4 2016 13F Holders as of 31 Dec 2016

Holder snapshot 7 signals
Share change
+1,791,948
Put/Call ratio
253%
SEC-reported price per share
$28.15
Indexed holders
122
Value change
+$50,764,547
Number of buys
68
Open additional details 1 more signal available
Number of sells
54
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
154,050,897

Security key

19249H103

Report period

Q4 2016

Indexed institutions

122

Top holders

10

Ownership snapshot

Top reported holders of CHRS - Coherus Oncology, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
0/15
Latest evidence
30 Sep 2016
13F Highest disclosed value: $174,259,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

FMR LLC has the largest disclosed position value at $174.26M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FMR LLC's linked filing trail.
Disclosed position value Top 5
FMR LLC $174.26M
Kohlberg Kravis Roberts & Co. L.P. $81.81M
JPMORGAN CHASE & CO $51.71M
WELLINGTON MANAGEMENT GROUP LLP $41.52M
BlackRock Fund Advisors $37.22M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
FMR LLC
13F
Company
13F
—
denominator unverified
$174,259,000
6,507,031 shares
— 30 Sep 2016
Kohlberg Kravis Roberts & Co. L.P.
13F
Company
13F
—
denominator unverified
$81,814,000
3,055,055 shares
— 30 Sep 2016
JPMORGAN CHASE & CO
13F
Company
13F
—
denominator unverified
$51,712,000
1,930,979 shares
— 30 Sep 2016
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
—
denominator unverified
$41,515,000
1,550,233 shares
— 30 Sep 2016
BlackRock Fund Advisors
13F
Company
13F
—
denominator unverified
$37,219,000
1,389,802 shares
— 30 Sep 2016
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$27,575,000
1,029,701 shares
— 30 Sep 2016
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2016

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
122
Shares
29,921,898
Indexed holders
122
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q4 2016 vs Q3 2016 Across Filers

Q3 2016 indexed holders
116
Q4 2016 indexed holders
122
Indexed holder difference
6
Investor Q3 2016 Shares Q4 2016 Shares Share Diff Share Chg % Q3 2016 value Q4 2016 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .